West Bengal, India

Chinmay Pal

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Council of Scientific and Industrial Research, University of Calcutta. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chinmay Pal. Retrieved from https://idiyas.com/inventor/chinmay-pal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Chinmay Pal: Pioneering Tryptamine Derivatives

Introduction

Chinmay Pal, an inventor based in West Bengal, India, has made significant contributions to the field of pharmaceuticals with his research on tryptamine derivatives. His innovative work focuses on the synthesis and evaluation of these compounds for their gastroprotective effects, showcasing his dedication to addressing health challenges posed by common medications.

Latest Patents

Chinmay Pal holds a patent for "Tryptamine derivatives, their preparation and their use in gastropathy." His research highlights the synthesis of various tryptamine derivatives that exhibit excellent antioxidant properties in vitro. Among these, the compound SEGA (3a), created through the combination of serotonin and gallic acid, stands out due to its superior antioxidant efficacy compared to other synthesized compounds. SEGA (3a) demonstrates a gastroprotective effect against NSAIDs-induced gastropathy and helps accelerate healing from gastric injuries.

Career Highlights

Chinmay has worked with prestigious institutions such as the Council of Scientific & Industrial Research and the University of Calcutta. His career is marked not only by his patent but also by his commitment to advancing scientific knowledge and improving therapeutic outcomes. His research indicates that SEGA (3a) can mitigate mitochondrial oxidative stress and prevent apoptosis, making it a potent candidate for further development in gastroprotective therapies.

Collaborations

Throughout his career, Chinmay Pal has collaborated with esteemed colleagues, including Uday Bandyopadhyay and Samik Bindu. These collaborations have likely contributed to the depth and breadth of his research, facilitating the exchange of ideas and expertise that propels scientific innovation.

Conclusion

Chinmay Pal's work on tryptamine derivatives exemplifies the impact of innovation in the pharmaceutical sector. By developing compounds that effectively combat NSAID-induced gastropathy, he not only advances medical research but also holds the potential to improve patient care. His contributions highlight the importance of interdisciplinary collaboration and continued research in the field of gastroenterology and antioxidant therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…